COVID-19 could cause infection in persons with opioid use disorder, increase opioid overdose rates, reverse system-level gains in expanding access to medication for opioid use disorder, halt critical research, and prevent exacting legal reparations against opioid manufacturers. The authors call for urgent action to counteract these risks.
All Keywords
【저자키워드】 COVID-19, Health care, opioids, Telemedicine, drug delivery, drug therapy, hospital medicine, Drug administration, Opioid addiction, Research laboratories,
【저자키워드】 COVID-19, Health care, opioids, Telemedicine, drug delivery, drug therapy, hospital medicine, Drug administration, Opioid addiction, Research laboratories,